Literature DB >> 18254928

The eleven-year switch of peptide aptamers.

Pierre Colas1.   

Abstract

Peptide aptamers are combinatorial recognition proteins that were introduced more than ten years ago. They have since found many applications in fundamental and therapeutic research, including their recent use in microarrays to detect individual proteins from complex mixtures.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18254928      PMCID： PMC2246034          DOI： 10.1186/jbiol64

Source DB:  PubMed          Journal:  J Biol        ISSN： 1475-4924


  25 in total

1.  Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.

Authors:  Michael Albers; Harald Kranz; Ingo Kober; Carmen Kaiser; Martin Klink; Jörg Suckow; Rainer Kern; Manfred Koegl
Journal:  Mol Cell Proteomics       Date:  2004-12-15       Impact factor: 5.911

2.  Design and validation of a neutral protein scaffold for the presentation of peptide aptamers.

Authors:  Robbie Woodman; Johannes T-H Yeh; Sophie Laurenson; Paul Ko Ferrigno
Journal:  J Mol Biol       Date:  2005-10-07       Impact factor: 5.469

3.  An antiproliferative genetic screening identifies a peptide aptamer that targets calcineurin and up-regulates its activity.

Authors:  Benoît de Chassey; Ivan Mikaelian; Anne-Laure Mathieu; Marc Bickle; Delphine Olivier; Didier Nègre; François-Loïc Cosset; Brian B Rudkin; Pierre Colas
Journal:  Mol Cell Proteomics       Date:  2006-12-04       Impact factor: 5.911

4.  Selection and characterization of large collections of peptide aptamers through optimized yeast two-hybrid procedures.

Authors:  Marc B T Bickle; Eric Dusserre; Olivier Moncorgé; Hélène Bottin; Pierre Colas
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 5.  High-throughput proteomics using antibody microarrays: an update.

Authors:  Carl A K Borrebaeck; Christer Wingren
Journal:  Expert Rev Mol Diagn       Date:  2007-09       Impact factor: 5.225

6.  Modulation of Nr-13 antideath activity by peptide aptamers.

Authors:  A-L Nouvion; J Thibaut; O D Lohez; S Venet; P Colas; G Gillet; P Lalle
Journal:  Oncogene       Date:  2006-08-14       Impact factor: 9.867

7.  Peptide aptamer-mediated inhibition of target proteins by sequestration into aggresomes.

Authors:  Evangelia Tomai; Karin Butz; Claudia Lohrey; Fritz von Weizsäcker; Hanswalter Zentgraf; Felix Hoppe-Seyler
Journal:  J Biol Chem       Date:  2006-05-22       Impact factor: 5.157

8.  Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.

Authors:  Sabine Gilch; Claudia Kehler; Hermann M Schätzl
Journal:  J Mol Biol       Date:  2007-05-25       Impact factor: 5.469

9.  A comparative analysis of perturbations caused by a gene knock-out, a dominant negative allele, and a set of peptide aptamers.

Authors:  Nadia Abed; Marc Bickle; Bernard Mari; Matthieu Schapira; Raquel Sanjuan-España; Karine Robbe Sermesant; Olivier Moncorgé; Sandrine Mouradian-Garcia; Pascal Barbry; Brian B Rudkin; Marie-Odile Fauvarque; Isabelle Michaud-Soret; Pierre Colas
Journal:  Mol Cell Proteomics       Date:  2007-09-04       Impact factor: 5.911

10.  Electrical protein detection in cell lysates using high-density peptide-aptamer microarrays.

Authors:  David Evans; Steven Johnson; Sophie Laurenson; A Giles Davies; Paul Ko Ferrigno; Christoph Wälti
Journal:  J Biol       Date:  2008
View more
  7 in total

Review 1.  Overview: the maturing of proteomics in cardiovascular research.

Authors:  Jennifer E Van Eyk
Journal:  Circ Res       Date:  2011-02-18       Impact factor: 17.367

2.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

3.  Inhibition of human cytomegalovirus replication via peptide aptamers directed against the nonconventional nuclear localization signal of the essential viral replication factor pUL84.

Authors:  Nina Kaiser; Peter Lischka; Nadine Wagenknecht; Thomas Stamminger
Journal:  J Virol       Date:  2009-09-09       Impact factor: 5.103

Review 4.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.

Authors:  Nicolas Bertrand; Jun Wu; Xiaoyang Xu; Nazila Kamaly; Omid C Farokhzad
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

Review 5.  Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomics.

Authors:  Emil Paleček; Jan Tkáč; Martin Bartošík; Tomáš Bertók; Veronika Ostatná; Jan Paleček
Journal:  Chem Rev       Date:  2015-02-09       Impact factor: 60.622

6.  Targeting cancer with peptide aptamers.

Authors:  Renaud Seigneuric; Jessica Gobbo; Pierre Colas; Carmen Garrido
Journal:  Oncotarget       Date:  2011-07

7.  The inhibition of stat5 by a Peptide aptamer ligand specific for the DNA binding domain prevents target gene transactivation and the growth of breast and prostate tumor cells.

Authors:  Axel Weber; Corina Borghouts; Christian Brendel; Richard Moriggl; Natalia Delis; Boris Brill; Vida Vafaizadeh; Bernd Groner
Journal:  Pharmaceuticals (Basel)       Date:  2013-08-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.